Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Novak

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Oncotarget|January 5, 2018
New role of ID3 in melanoma adaptive drug-resistanceSachindra, Lionel Larribère, Daniel Novak, et al.
International Journal of Cancer|August 16, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulationHuizi Wu, Lionel Larribère, Qian Sun, et al.
Plos One|October 28, 2017
Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trialMarie Hagbom, Daniel Novak, Malin Ekström, et al.
The Western Journal of Emergency Medicine|December 3, 2024
Teaching the New Ways: Improving Resident Documentation for the New 2023 Coding RequirementsNathan Zapolsky, Annemarie Cardell, Riddhi Desai, et al.
Annals of Plastic Surgery|March 24, 2026
Comparative Analysis of Breast Implant Illness Symptoms in Implant-Based, Autologous, and No-Reconstruction Mastectomy Patients: A TriNetX Database StudyYash A Mehta, Emmi Deckard, Medha Vallurupalli, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
The European Journal of Neuroscience|November 19, 2025
Precise Electrode Co-Alignment in Deep Brain Stimulation Fusing Neuroimaging and ElectrophysiologyIgor Varga, Daniel Novak, Dusan Urgosik, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
International Journal of Cancer|June 16, 2018
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanomaLaura Hüser, Sachindra Sachindra, Karol Granados, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Oncotarget|January 5, 2018
New role of ID3 in melanoma adaptive drug-resistanceSachindra, Lionel Larribère, Daniel Novak, et al.
International Journal of Cancer|August 16, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulationHuizi Wu, Lionel Larribère, Qian Sun, et al.
Plos One|October 28, 2017
Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trialMarie Hagbom, Daniel Novak, Malin Ekström, et al.
The Western Journal of Emergency Medicine|December 3, 2024
Teaching the New Ways: Improving Resident Documentation for the New 2023 Coding RequirementsNathan Zapolsky, Annemarie Cardell, Riddhi Desai, et al.
Annals of Plastic Surgery|March 24, 2026
Comparative Analysis of Breast Implant Illness Symptoms in Implant-Based, Autologous, and No-Reconstruction Mastectomy Patients: A TriNetX Database StudyYash A Mehta, Emmi Deckard, Medha Vallurupalli, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
The European Journal of Neuroscience|November 19, 2025
Precise Electrode Co-Alignment in Deep Brain Stimulation Fusing Neuroimaging and ElectrophysiologyIgor Varga, Daniel Novak, Dusan Urgosik, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
International Journal of Cancer|June 16, 2018
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanomaLaura Hüser, Sachindra Sachindra, Karol Granados, et al.
Pageof 8